Compare FATE & CMTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FATE | CMTL |
|---|---|---|
| Founded | 2007 | 1967 |
| Country | United States | United States |
| Employees | N/A | 1385 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Radio And Television Broadcasting And Communications Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 125.6M | 133.7M |
| IPO Year | 2013 | 2024 |
| Metric | FATE | CMTL |
|---|---|---|
| Price | $3.16 | $1.91 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 1 |
| Target Price | $4.10 | ★ $6.00 |
| AVG Volume (30 Days) | ★ 4.6M | 1.2M |
| Earning Date | 05-14-2026 | 06-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.88 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $6,646,000.00 | ★ $499,528,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $4.56 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.91 | $1.80 |
| 52 Week High | $3.21 | $6.21 |
| Indicator | FATE | CMTL |
|---|---|---|
| Relative Strength Index (RSI) | 68.67 | 30.68 |
| Support Level | $1.01 | N/A |
| Resistance Level | $3.21 | $3.41 |
| Average True Range (ATR) | 0.30 | 0.17 |
| MACD | 0.08 | 0.01 |
| Stochastic Oscillator | 92.49 | 16.70 |
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. The company is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.
Comtech Telecommunications Corp is a provider of communications technology and solutions. It operates in two reportable business segments: Satellite and Space Communications and Allerium. The company's Satellite and Space Communications segment, which generates maximum revenue, is organized into four technology areas: satellite modem and amplifier technologies, troposcatter technologies, cybersecurity training, and space components. This segment designs and manufactures modems, amplifiers, traveling wave tube amplifiers, frequency converters, and offers other associated software and services. The Allerium segment provides next-generation 911 (NG-911) infrastructure and solutions for state and local governments and carriers. Geographically, the company derives its key revenue from the USA.